Esomeprazole Magnesium Capsule, Delayed Release Pellets
Product Images NDC 71335-1170

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 71335-1170). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Esomeprazole Magnesium Delayed Release Capsules Us 1)

Chemical structure of esomeprazole magnesium. The diagram shows two esomeprazole molecules coordinated with a magnesium ion (Mg2+) and two water molecules (2 H2O), illustrating the key molecular composition of this active ingredient.*

FDA Label Image

Figure 2: Maintenance Of Healing Rates By Month (study 177) (Esomeprazole Magnesium Delayed Release Capsules Us 2)

A line graph showing the percent maintained over six months for Esomeprazole Magnesium delayed-release capsules at 10 mg, 20 mg, and 40 mg doses compared with placebo. The x-axis represents months with scheduled visits, and the y-axis represents percent maintained. The 40 mg dose maintains the highest percentage over time, followed by 20 mg, 10 mg, and placebo.*

FDA Label Image

Figure 3: Maintenance Of Healing Rates By Month (study 178) (Esomeprazole Magnesium Delayed Release Capsules Us 3)

A line chart showing the percent maintained response over six months for Esomeprazole Magnesium Delayed-release Capsules at 10 mg, 20 mg, and 40 mg doses compared with placebo. The x-axis represents months with scheduled visits, and the y-axis shows the percent maintained. The 40 mg dose maintains the highest percentage, followed by 20 mg, 10 mg, and placebo.*

FDA Label Image

Figure 4 (Esomeprazole Magnesium Delayed Release Capsules Us 4)

A line graph displaying the percent of patients symptom-free over 28 diary days. The x-axis represents diary days from 0 to 28, and the y-axis shows the percentage of symptom-free patients from 0 to 100. Three lines represent Esomeprazole Magnesium delayed-release capsules 40 mg, 20 mg, and placebo, with the chart showing symptom-free percentages increasing over time for all groups but higher for 40 mg and 20 mg doses compared to placebo.*

FDA Label Image

Figure 5 (Esomeprazole Magnesium Delayed Release Capsules Us 5)

Line graph showing the percent of patients symptom-free over a 28-day diary period. Three treatment groups are compared: Esomeprazole Magnesium delayed-release capsules 40 mg, 20 mg, and placebo. The y-axis represents the percent symptom-free, and the x-axis shows diary days from 0 to 28. A legend identifies each line type for the 40 mg, 20 mg doses, and placebo.*

FDA Label Image

Label Image (Lbl713351170)

Label for Esomeprazole Magnesium DR 20 mg capsule, delayed release pellets, packaged by Bryant Ranch Prepack in Burbank, CA. The capsule color is dark blue and white. The label indicates a quantity of 30 capsules and compares the product to Nexium 20 mg capsule by Lannett Company Inc. Storage instructions are included along with a barcode and the NDC 71335-1170.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.